NCT00001689
- Conditions
- Acute Lymphocytic Leukemia, Chemically-Induced Disorders, Hematologic Diseases, +13 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
Clinical trial condition
Leukemia
Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.
1,217 public trials
94 recruiting studies
Leukemia trial results
NCT00042445
- Conditions
- Brain Diseases, Brain Neoplasm, Brain Neoplasms, +10 more
- Locations
-
- Harvard School of Public Health Boston, Massachusetts, United States
- Kaohsiung Medical University Kaohsiung City, Taiwan
NCT00082303
- Conditions
- Anxiety Disorders, Behavior, Behavioral Symptoms, +13 more
- Locations
-
- Indiana University Cancer Center/University Hospital Indianapolis, Indiana, United States
Completed
Protection Against Benzene Toxicity
NCT00011453
- Conditions
- Anemia, Anemia, Aplastic, Aplastic Anemia, +7 more
- Locations
-
- University of Colorado Health Sciences Center Denver, Colorado, United States
Active, Not Recruiting
Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors
NCT06053268
- Conditions
- Childhood Cancer, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
Active, Not Recruiting
A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia
NCT02251548
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- University of Miami Sylvester Comprehensive Cancer Center Coral Gables, Florida, United States
- University of Miami Sylvester Comprehensive Cancer Center Deerfield Beach, Florida, United States
- Unversity of Miami Sylvester Comprehensve Cancer Center Miami, Florida, United States
- University of Kansas Cancer Center Westwood, Kansas, United States
Active, Not Recruiting
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
NCT01608152
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
NCT06578247
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
- Locations
-
- City of Hope Phoenix Goodyear, Arizona, United States
- Mayo Clinic - Phoenix Phoenix, Arizona, United States
- University of Arizona Cancer Center Tucson, Arizona, United States
- David Geffen School of Medicine Los Angeles, California, United States
Active, Not Recruiting
Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion
NCT03722407
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +11 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Weill Medical College of Cornell University New York, United States
Active, Not Recruiting
Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)
NCT01446133
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States